There are plenty of good reasons to consider putting more of your hard-earned money into companies that offer necessary goods, generate stable revenue, and are consistently profitable. Inflation is reining in consumer spending, meaning those goods that are must-haves tend to be prioritized. Furthermore, with interest rates rising, speculative growth stocks will be hit harder than stocks of more established corporations.

With that in mind, let's look at two relatively safe options in the stock market right now: Bristol Myers Squibb (NYSE: BMY) and Merck & Co. (NYSE: MRK). Both of these drugmakers have outperformed the broader market this year. Here's why.

Continue reading

Source Fool.com